Works matching DE "HORMONE antagonists"


Results: 834
    1
    3
    4
    6
    7
    8
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Calcimimetics and outcomes in CKD.

    Published in:
    Kidney International Supplements, 2013, v. 3, n. 5, p. 431, doi. 10.1038/kisup.2013.90
    By:
    • Drüeke, Tilman B
    Publication type:
    Article
    27
    28
    29
    30
    31

    Introduction.

    Published in:
    Prostate Cancer & Prostatic Diseases, 2004, v. 7, p. S1, doi. 10.1038/sj.pcan.4500740
    By:
    • Anderson, J.;
    • Schalken, J. A.
    Publication type:
    Article
    32
    33
    34
    35

    Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

    Published in:
    Life (2075-1729), 2023, v. 13, n. 5, p. 1072, doi. 10.3390/life13051072
    By:
    • Sugino, Fumiya;
    • Nakane, Keita;
    • Kawase, Makoto;
    • Ueda, Shota;
    • Tomioka, Masayuki;
    • Takeuchi, Yasumichi;
    • Tomioka-Inagawa, Risa;
    • Yamada, Toyohiro;
    • Namiki, Sanae;
    • Kumada, Naotaka;
    • Takeuchi, Shinichi;
    • Kawase, Kota;
    • Kato, Daiki;
    • Takai, Manabu;
    • Iinuma, Koji;
    • Tobisawa, Yuki;
    • Koie, Takuya
    Publication type:
    Article
    36

    Current management of chronic kidney disease in type‐2 diabetes—A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD‐UKKA) guidelines.

    Published in:
    Diabetic Medicine, 2025, v. 42, n. 2, p. 1, doi. 10.1111/dme.15450
    By:
    • Dasgupta, Indranil;
    • Zac‐Varghese, Sagen;
    • Chaudhry, Khuram;
    • McCafferty, Kieran;
    • Winocour, Peter;
    • Chowdhury, Tahseen A.;
    • Bellary, Srikanth;
    • Goldet, Gabrielle;
    • Wahba, Mona;
    • De, Parijat;
    • Frankel, Andrew H.;
    • Montero, Rosa M.;
    • Lioudaki, Eirini;
    • Banerjee, Debasish;
    • Mallik, Ritwika;
    • Sharif, Adnan;
    • Kanumilli, Naresh;
    • Milne, Nicola;
    • Patel, Dipesh C.;
    • Dhatariya, Ketan
    Publication type:
    Article
    37

    Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

    Published in:
    Diabetic Medicine, 2018, v. 35, n. 10, p. 1375, doi. 10.1111/dme.13669
    By:
    • Tofte, N.;
    • Lindhardt, M.;
    • Frimodt‐Møller, M.;
    • Persson, F.;
    • Rossing, P.;
    • Dimos, I.;
    • Francová, L.;
    • Rychlík, I.;
    • Girman, P.;
    • Havrdova, T.;
    • Göke, R.;
    • Kooy, A.;
    • Mischak, H.;
    • Navis, G.;
    • Nijpels, G.;
    • Noutsou, M.;
    • Ortiz, A.;
    • Adamova, K.;
    • Parvanova, A.;
    • Ruggenenti, P. L.
    Publication type:
    Article
    38
    39
    41

    Upacicalcet: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 13, p. 1593, doi. 10.1007/s40265-021-01578-y
    By:
    • Hoy, Sheridan M.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50